Literature DB >> 7955968

The direct cost of type 1 diabetes mellitus in Israel.

Z Stern1, R Levy.   

Abstract

Estimates of the cost of Type 1 (insulin-dependent) diabetes mellitus should take into account the development of various complications. In this study, we calculated separately the basic direct costs of a Type 1 diabetic patient over a span of 35 years of living with the disease, and on average, the cost of complications which developed during this period of time. Assessment of costs showed that there is a difference between the cost of treating the disease itself, which decreases over the years, and the cost of treating its complications, which increases. The cost of treating one patient over the 35-year period amounted to about 247,000 pounds in 1993 prices, and in terms of discount value, to about 104,000 pounds. These costs are significant in planning the health expenditure and the investment of resources for prevention of the disease, and in selecting proper methods of treatment of complications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955968     DOI: 10.1111/j.1464-5491.1994.tb02031.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

2.  Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.

Authors:  L Garattini; M Brunetti; F Salvioni; M Barosi
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 3.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

4.  Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications.

Authors:  Z Stern; R Levy
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

5.  The cost of type 1 diabetes: a nationwide multicentre study in Brazil.

Authors:  Roberta Arnoldi Cobas; Marcos Bosi Ferraz; Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Carlos Antonio Negrato; Luiz Antonio de Araujo; Sergio Atala Dib; Marilia Brito Gomes
Journal:  Bull World Health Organ       Date:  2013-04-04       Impact factor: 9.408

Review 6.  Cost-of-illness studies in diabetes mellitus.

Authors:  Lorraine Ettaro; Thomas J Songer; Ping Zhang; Michael M Engelgau
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.